The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis
Clinical trial NCT06470386 · UNKNOWN
Trial details
- NCT number
- NCT06470386
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-11-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.